Effects of Inhaled Inactivated Mycobacterium phlei on Airway Inflammation in Mouse Asthmatic Models
Authors:
- 8 December 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Vol. 25 (2) , 96-103
Abstract
Background: Corticosteroids are the most efficacious anti-inflammatory drugs for asthma therapy; however, steroids are not always completedly effective for asthma. Studies have shown Mycobacterium bovis Bacille Calmette-Guérin (BCG) and other mycobacterial infections suppress airway hyperresponsiveness and inflammation in asthma. We use a murine model of Ovalbumin (OVA)-induced asthma to study whether nebulized inhalation of inactivated Mycobacterium phlei can alleviate asthmatic airway inflammation through influencing cytokine production and determine whether it can prevent and treat asthma. Methods: Fifth male Balb/c mice were randomly divided into four groups: normal control group (A), asthma model group (B0, B3, B4, B5), the treatment group (C0, C3, C4, C5), and prevention group (D). Mice were sensitizated and challenged with Ovalbumin to make a murine asthma model. Group C were given treatment of aerosol Mycobacterium phlei once daily after OVA challenge. Groups C3, C4, and C5 were treated for 3 days, 4 days, and 5 days, respectively. Group D inhaled the solution of inactivated Mycobacterium phlei daily before each time of OVA challenge. All the animals were killed and lung tissue and bronchoalveolar lavage fluid (BALF) were harvested. Pathological HE staining and AB-PAS staining were done to measure lung inflammation and mucus production. Total cell numbers and differential cell count in BALF were performed. Cytokines IL-4, IL-10, and IFN-γ levels in BALF were quantified by ELISA. Results: In groups C4, C5, and D, IL-4 production in BALF was decreased and IL-10 and IFN-γ were increased ( p p Mycobacterium phlei can reduce airway inflammation in asthmatic mice. This ability was associated with its immunomodulatory effect on regulating IL-4, IL-10, and IFN-γ secretion. Aerosol administration of inactivated Mycobacterium phlei may be accepted as an alternative method with less risk of adverse reactions in treatment of asthma.Keywords
This publication has 29 references indexed in Scilit:
- Thalidomide Attenuates Airway Hyperresponsiveness and Eosinophilic Inflammation in a Murine Model of Allergic AsthmaBiological and Pharmaceutical Bulletin, 2010
- Functionally important role for arginase 1 in the airway hyperresponsiveness of asthmaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Acute exacerbations of asthma: epidemiology, biology and the exacerbation‐prone phenotypeClinical & Experimental Allergy, 2009
- The Distinctive Effects of Acute and Chronic Psychological Stress on Airway Inflammation in a Murine Model of Allergic AsthmaAllergology International, 2007
- The global burden of asthma: executive summary of the GINA Dissemination Committee ReportAllergy, 2004
- Current and Emerging Nonsteroidal Anti-Inflammatory Therapies Targeting Specific Mechanisms in Asthma and AllergyTreatments in Respiratory Medicine, 2004
- Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cellsNature Medicine, 2002
- Airway Hyperresponsiveness, Late Allergic Response, and Eosinophilia Are Reversed with Mycobacterial Antigens in Ovalbumin-Presensitized MiceThe Journal of Immunology, 2002
- Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cellsBritish Journal of Cancer, 1998
- The Inverse Association Between Tuberculin Responses and Atopic DisorderScience, 1997